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Assessment of Parylene C Thin Films
for Heart Valve Tissue Engineering
Isra Marei,1–3,* Adrian Chester,1,2,* Ivan Carubelli,1 Themistoklis Prodromakis,4,5
Tatiana Trantidou,4,5 and Magdi H. Yacoub1,2
Background: Scaffolds are a key component of tissue-engineered heart valves (TEHVs). Several approaches
had been adopted in the design of scaffolds using both natural and synthetic resources. We have investigated the
suitability of parylene C (PC), a vapor deposited polymeric material, for the use as a scaffold in TEHV.
Aims: To evaluate the adsorption of extracellular matrix components onto plasma-activated PC and study the
biocompatibility of PC by measuring cellular adhesion, viability, apoptosis, and phenotypic expression of valve
endothelial and interstitial cells. Finally, the mechanical properties of PC were compared with those of native
aortic valve cusp tissue.
Methods: PC slides were plasma activated and then coated with gelatin, type I collagen, or fibronectin. Porcine
pulmonary valve endothelial and interstitial cells were then grown on plasma oxidized PC with different types
of coatings and their adhesion was observed after 20 h of incubation. Cell viability was tested using the MTS
assay, and apoptosis was estimated using TUNEL staining. The mechanical properties of PC and valve tissue
were measured using a Bose Mechanical Tester. Finally, cell-seeded PC films were exposed to pulsatile
pressure and aortic shear stress, respectively, to test their durability in a dynamic environment.
Results: Our findings show that collagen and fibronectin could bind to plasma oxidized PC. Both valve endo-
thelial and interstitial cells adhered to protein-coated ECM. PC had a profile of mechanical stiffness and ultimate
tensile strength that were comparable with or in excess of those seen in porcine aortic valve cusps. Cells were still
attached to PC films after 3 days of exposure to up to 50mmHg pulsatile pressure or aortic levels of shear stress.
Conclusion: PC is a promising candidate for use as a scaffold in tissue engineering heart valves. Additional
studies are required to determine both the durability and long-term performance of cell-seeded PC when in a
similar hemodynamic environment to that of the aortic valve.
Introduction
D iseases of the heart are the number one cause ofdeath worldwide, resulting in 9.4 million deaths annu-
ally according to the World Health Organization. A con-
siderable proportion of these deaths are caused by valvular
heart disease (VHD), where the valve fails to function
properly, leading to heart failure.1 The only treatment of
end-stage VHD is the surgical replacement of the diseased
valve with a prosthetic substitute.2 Although the available
prostheses increase the life quality and expectancy, they are
still associated with limitations that affect their perfor-
mance, such as thrombogenicity and structural failure.1
Therefore, efforts are focused on providing a biocompatible
viable valve replacement that overcomes the limitations of
the available prostheses, in addition to providing an intrinsic
repair mechanism, with the ability to remodel and adapt to
the hemodynamic changes.
Tissue engineering can offer a solution to this problem.
Several approaches have been made to design scaffolds
suitable for tissue-engineered heart valves (TEHVs), both
from natural and synthetic resources, but most of the in-
vestigated materials have limitations, especially in regard to
their mechanical properties. Examples of natural scaffolds
are those made of collagen and fibrin, which provide good
interaction with the cells, but show weak mechanical
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properties.3,4 Synthetic materials from the aliphatic polyes-
ter family had been studied, such as polyglycolic acid
(PGA) and polylactic acid (PLA). These polymers are
highly stiff and nonpliable, making the fabrication of scaf-
folds a difficult process.5 To overcome the limitations of
both types of scaffolds, several studies attempted to com-
bine thin synthetic films with extracellular matrix (ECM)
components, thus integrating the structural and mechanical
properties of synthetic scaffolds with the natural biocom-
patible ingredients of ECM.6 In the current study, we adapt
this approach, testing parylene C (PC) thin polymeric films
supported with collagen or fibronectin.
Poly(chloro-para-xylynene) or PC is a member of the
family of parylene polymers that are produced through the
chemical vapor deposition (CVD) process and are widely
used in biomedical applications.7 PC is characterized by its
biocompatibility and mechanical robustness and therefore it
has been used in coating surgical tools and implantable
biomedical devices.8,9 Since PC can be deposited as a
continuous nonporous layer, it has been used as a coating to
protect sensitive components of biomedical implants, such
as blood pressure sensors and cardiac assist devices.10 In
addition, PC stencils have been used for cell and protein
patterning and for coculture generation.11 Recently, the use
of PC as a scaffolding material in tissue engineering has
been studied.12–15 To evaluate PC suitability for TEHV, a
thorough understanding of its mechanical and physical
properties is essential. PC is easy to fabricate, forming a thin
uniform pinhole-free coating.12 The process of depositing
PC starts by the decomposition of vaporized dichlorodi-
p-xylylene, a low-molecular-weight dimer, to produce
chloro-p-xylylene, which is then polymerized to the high-
molecular-weight PC.7,12 In terms of mechanical properties,
PC possesses high strength and stiffness.11 In addition, it is a
nondegradable, chemically inert nontoxic polymer that is
highly stable in the biological system, possessing a high
level of biocompatibility, according to the US Pharmaco-
peia.12 Nonetheless, one factor that could limit the use of PC
in biomedical applications is its hydrophobicity. This can be
resolved by plasma oxidizing PC films resulting in the de-
struction of chemical bonds, making them hydrophilic.12,16
The biocompatibility and ease of fabrication of PC make
it a promising candidate as a scaffolding material for TEHV.
Thus, we hypothesize that PC thin films will provide the
desired interaction with valve cells and will be mechanically
suitable for a scaffold of TEHVs. The aim of the current
study is to assess PC film compatibility for use in heart valve
tissue engineering. In this very early stage of designing a PC
scaffold, we have evaluated PC adsorption to collagen and
fibronectin, and its biocompatibility with valve endothelial
and interstitial cells by assessing cellular adhesion, viability,
apoptosis, and phenotypic expression. In addition, we have
compared PC mechanical properties to that of the aortic
valve by measuring Young’s modulus, yield stress, and ul-
timate tensile strength (UTS).
Materials and Methods
Deposition and plasma oxidation of PC
PC was deposited on microscope glass slides by CVD.
Briefly, standard glass slides (76· 26mm) were cleaned in
acetone and isopropanol and rinsed with deionized water.
Slides were then dehydrated for 60 s at 90C. Thin films of
PC (1.5–6 mm) were deposited through CVD using a
(PDS2010) coater (SCS Coating) by vaporizing at 150C
followed by PC dimer pyrolization at 690C. The film
thickness was determined through calibration samples
where PC was removed and measured by a Dektak 6M
Stylus profiler (Veeco Instruments). PC-coated slides were
then oxygen plasma treated using the FEMTO plasma sys-
tem (Diener Electronics) at 0.1mbar and 50W for 10min.
Two PC-coated slides were kept untreated (hydrophobic) to
compare hydrophilicity and cellular adhesion. To test the
wettability of PC, 10mL of trypan blue was pipetted on the
surface of each sample, and images were captured using
high-resolution mobile camera. The contact angle was
measured using ImageJ (NIH).
Surface protein staining
To determine PC adsorption to ECM proteins, a plasma
oxidized PC slide was divided using a flexiPERM reusable
12-well cell culture chamber (Greiner Bio-One), and wells
were coated with either 2.1mg/m type I rat tail collagen
(First Link LTD) for 30min or 10 mg/mL human fibronectin
(PromoCell) for 1 h. Both coatings were done at room
temperature, and uncoated wells were included as negative
controls. The sample was compared to a microscope slide
with the same treatments. After incubation, qualitative
staining was performed using picrosirius red staining of
collagen, and immunofluorescent staining of fibronectin-
coated wells using antifibronectin MAbs (Novotec).
Isolation and cell culture of pulmonary valve
endothelial and interstitial cells
Whole hearts from pigs were obtained from an abattoir
(Turner’s Abattoir). Pulmonary valve endothelial cells
(VECs) and pulmonary valve interstitial cells (VICs) were
isolated from freshly dissected pig pulmonary valves by
collagenase digestion, as previously described.17 Valve
cusps were dissected from the root, washed several times
with Dulbecco’s phosphate-buffered saline (DPBS) (Sigma
Aldrich), and then incubated in collagenase type II (Sigma
Aldrich) for 10min at 37C with shaking. Collagenase was
deactivated by fetal bovine serum (FBS) (Sigma Aldrich),
the digest was centrifuged, and the endothelial cell pellet
was resuspended in the endothelial cell growth medium
(EGM) (PromoCell) and transferred to six-well plates
coated with 1% gelatin (Sigma Aldrich). To isolate VICs,
valves were further incubated in collagenase for 45min at
37C. Collagenase was then deactivated by FBS, and cells
were pelleted followed by resuspension in Dulbecco’s
Modified Eagle’s Medium (DMEM) (Sigma Aldrich). VICs
were then seeded into six-well plates. Cells were grown to
confluence and then transferred to T25 flasks. Pulmonary
valve endothelial cells (PVECs) were grown in the ECM 2
supplemented with endothelial cell growth medium (EGM-
2) (PromoCell), 1% penicillin–streptomycin, 1% glutamine,
and 20% fetal calf serum (FCS), whereas pulmonary valve
interstitial cells (PVICs) were maintained in DMEM sup-
plemented with 10% FCS, 1% penicillin–streptomycin, and
1% glutamine (all obtained from Sigma Aldrich). All cell
cultures were maintained in a 37C incubator with 5%
carbon dioxide, and media were renewed every 3 days.
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Assessment of PC cell compatibility
To validate the effect of PC on VEC morphology and
adhesion, three groups of plasma oxidized PC-coated slides
were used with the following treatments: (1) 1% gelatin
coating for 20min, (2) 2.1mg/mL type I rat tail collagen
coating for 30min, and (3) 10 mg/mL fibronectin coating
for 1 h. Fibronectin and collagen were chosen since they
are both present in the valve ECM, while gelatin is a
standard protein used to coat glass slides to allow cells to
attach and grow on the slides. Another group of PC-coated
slides without plasma oxidation was included as a negative
control. All of these treatments were compared to the
control group grown on sterile microscope slides with 1%
gelatin coating. Similar groups of coated slides were used
to evaluate the effect of PC on the morphology of VICs,
except that no gelatin coating was necessary for interstitial
cell attachment to glass or PC. Additional experiments
were conducted to evaluate the effect of PC on the pro-
liferation of VECs and VICs. The proliferation of cells on
slides coated with plasma oxidized PC without additional
coating was compared to plasma oxidized slides coated
with PC and a range of concentrations of collagen or fi-
bronectin (10–1000 mg/mL). Slides were attached to 12-
well cell culture chambers, and each well was seeded with
10–15 · 103 cells from passages 4–6 and incubated over-
night. Cell number and apoptosis (at a single concentration
of each ECM protein) were then studied on each of the
slides as described below.
Cell adhesion. After 20 h of incubation, cells were vi-
sualized using the Olympus light microscope, and three to
four different fields were captured to compare cellular ad-
hesion and morphology.
MTS cell proliferation assay. To determine the number
of viable cells, the CellTiter 96 AQueous NonRadioactive
Cell Proliferation assay (Promega) was performed fol-
lowing the manufacturer’s instructions. The kit is based on
the reduction of MTS (a tetrazolium compound) by meta-
bolically active cells to form a water soluble colored for-
mazan compound that is measured at 490 nm. The amount
of measured absorbance is directly proportional to the
number of viable cells. A standard curve for each type of
coating was performed, using five standards for both PVIC
and PVEC lines (10, 7, 5, 2, 1 · 103 cells). Samples and
standards were washed with DPBS to remove dead cells,
and 100 mL of fresh media was added to each well. A
mixture of PMS/MTS solution was prepared by adding
100 mL of PMS solution to 2mL MTS solution. Each well
was then loaded with 20 mL of PMS/MTS mixture and was
incubated for 1 h at 37C. Absorbance was measured at
490 nm using an ELISA plate reader, standard curves were
plotted using absorbance and cell numbers, and a trend line
was drawn using excel. The trend line’s equation was used
to determine numbers and percentages of viable cells.
Terminal deoxynucleotidyl transferase dUTP nick end la-
beling. To estimate the percentage of apoptotic cells, the
TUNEL assay was performed using an in situ Cell Death
Detection Kit (Roche). Apoptosis detection was assessed by
terminal deoxynucleotidyl transferase (TdT) labeling of
DNA breaks with modified nucleotides. Cells were fixed in
freshly prepared 4% paraformaldehyde in phosphate-buff-
ered saline (v/v) for 1 h at room temperature and were then
incubated for 2min in a permeabilization solution (0.1%
Triton X-100 in 0.1% sodium citrate). The TUNEL reaction
mixture was prepared by mixing 10mL of TdT with 90mL of
labeling solution. Cells were then washed, and 30mL of
TUNEL reaction mixture was added to each well and incu-
bated for 1 h at 37C. Cells were then stained with DAPI
(4¢,6-diamidino-2-phenylindole) nuclear stain, and slides
were mounted with mounting media. Cells were counted in
five to eight fields, and the percentage of apoptosis was de-
termined. A negative control was included for each treat-
ment, where the TdT enzyme was not added. In addition,
positive controls were induced by treatment with 100mmol
H2O2 (1 h in PVECs and 30min in PVICs), and the suitable
treatment duration was determined through a time course.
Mechanical testing of PC and comparison
with aortic valves
Preparation of aortic valves. Porcine aortic valve leaflets
(right coronary, left coronary, and noncoronary) were isolated
from the root and transferred to DPBS. Leaflets were cut in two
directions, circumferentially or radially, with a width of 5mm,
and were mechanically tested using the Bose instrument.
Uniaxial testing. Uniaxial testing of heart valves and
PC membranes was carried out using the Bose instrument
(Bose Electroforce), and data were acquired by WinTest
software. The width of the samples was measured using a
caliper, and the initial distance between the clamps was set
up to 8mm. The thickness of PC was measured using a
stylus profiler as described in the Materials and Methods
section, while leaflet thicknesses were determined micro-
scopically. Samples were loaded into the clamps, and
tensile testing was applied. Since PC films are very thin,
films were attached to the clamps using tape at each end to
avoid slipping of samples during testing.
Tissue samples were exposed to cyclic uniaxial extension
for 20 cycles with a frequency of 0.1Hz and a displacement
of 4mm. PC samples were tested using the stretch to failure
method, where samples were stretched at 0.1Hz with a speed
of 0.05mm/min to a maximum displacement of 5.8mm. The
machine applies gradual tensile load on the sample and re-
cords force and displacement throughout the experiment.
Young’s modulus and UTS were calculated for each
sample. This was done by drawing a stress–strain curve,
where the slope of the linear region of the curve is Young’s
modulus, and the maximum load the sample reaches before
failure is the UTS. To draw a stress–strain curve, stress (o˙)
was calculated by dividing the force (F) by the cross-sectional
area (A), where the cross-sectional area is equal to width (W)
multiplied by thickness (h) (Equation 1.1). Strain (e) was
calculated by dividing the change in length (Dl) by initial
length (l˚ ) (Equation 1.2). Data analysis and curve generation
were done using Excel.
Equation 1:1¼ F
A
where A¼W · h
Equation 1:2
Dl
l
where Dl¼ l l
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Dynamic evaluation of PC films with a pulsatile
bioreactor
Briefly, the bioreactor comprised two parts: the central
part being a pressurized windkessel chamber (by means of
an adjustable volume of air above the tissue culture me-
dium), surrounded by a second cylinder forming an ex-
ternal reservoir vented to the atmosphere with a 0.2-mm
syringe filter to maintain sterility and allow gas exchange.
The outer reservoir and the inner chamber were connected
to the inlet and outlet of a ventricular assist device (VAD),
respectively. The two chambers were also connected by
silicon tubing around which an adjustable gate clamp could
be placed. PC film mounted cassettes were mounted over
holes in the wall between the inner and outer chamber.
Instantaneous pressure profiles within the windkessel and
the reservoir were simultaneously recorded with trans-
ducers (6600 series amplifier; Edwards Lifesciences) that
had been precalibrated with a water column. The trans-
ducer output was connected to an analog-to-digital con-
verter (Model Micro 1401; Cambridge Electronic Design)
with proprietary data capture and analysis software (Spike
2, version 7). This allowed the instantaneous pressure
gradient across the valve to be determined. The VAD was
attached to a stepper motor (Placepower UK Ltd).18 Once
assembled, the bioreactor was moved into an incubator at
37C and 5% CO2 attached to the VAD. Pressure gradient
between the windkessel and the reservoir was set at 0–
50mmHg with the stepper motor set at 60 beats/min. These
conditions were kept for 3 days. PC films were then re-
moved from the cassettes and stained as previously de-
scribed with primary antibodies against vimentin (1:100)
(Dako).
Exposure of PC films to aortic flow patterns
PVECs were seeded overnight on the different coated
PC films; films were then peeled off, cut, and mounted in
a purpose-built flow chamber.19 The chamber is com-
posed of a spinning cone made with a 179 angle and a
cylindrical plate containing nine equally spaced wells
where PC films can be mounted. PC films were exposed
to a flow pattern simulating that of the aortic side of the
aortic valve for 3 days. This period was chosen since we
were confident from previous studies that the cells would
remain viable in the bioreactor over this time frame.
During exposure to flow, samples were kept at 37C, 5%
CO2 with DMEM supplemented with 0.4% FCS, 1%
penicillin–streptomycin, and 1% glutamine (all obtained
from Sigma Aldrich). After 3 days, films were washed
with DPBS and staining was performed as previously
described: cells were stained with TRITC-conjugated
phalloidin to look at cell shape and nuclei were stained
with DAPI.
Statistical analysis
Statistical analysis was carried out using GraphPad prism
statistical software. Data are expressed as mean – standard
deviation. Samples were tested using ANOVA, and upon
significance, multiple comparisons were done using the t-
test, followed by Bonferroni correction. A p-value < 0.05
was considered significant.
Results
PC hydrophobicity and contact angle
To check the effect of plasma oxidation in inducing
membrane hydrophobicity, the contact angles of plasma-
treated and nontreated PC membranes were compared. The
mean contact angle of the trypan blue drop was significantly
decreased from 55.5 – 3 to 18 – 1.3 after plasma treatment
of PC with 50% O2 for 10min (n= 2, p= 0.0001) (Fig. 1).
Biocompatibility of PC
Adsorption of ECM proteins onto PC. Plasma oxidized
PC slides were coated with collagen or fibronectin and then
stained to check for their adsorption of each protein. Fi-
bronectin adsorption was detected by immunofluorescence,
and fibronectin-coated PC showed positivity in a similar
pattern to the staining of fibronectin-coated microscopic
slide (n = 2) (Fig. 2A–C). Similarly, collagen-coated slides
were stained with picrosirius red, where collagen-coated PC
slides showed positivity (n= 2) (Fig. 2D–F).
PC compatibility with cell adhesion and viability. PVECs
show poor adhesion to plain glass slides; thus, to allow
attachment, it was necessary to coat the surface of the
control slides with gelatin. Cells attached only weakly to
nonplasma oxidized gelatin-coated PC slides. In contrast,
cell morphology and attachment were enhanced on plas-
ma-treated gelatin-coated PC slides, with a similar pattern
to control grown on gelatin-coated glass slides (Fig. 3A–
C). The number of PVECs grown on plasma oxidized PC
membranes remained stable, while those grown on PC
without plasma treatment were significantly reduced (Fig.
3F). Subsequently, all the following experiments were
carried out using plasma-treated PC.
FIG. 1. Wettability of parylene C (PC). The contact angle
of 10 mL trypan blue drop with PC was measured before
plasma treatment (A) and after plasma treatment (B) (n = 2,
p < 0.0001).
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FIG. 2. PC adsorption of fibronectin and collagen. (A–C) Staining of fibronectin using antifibronectin fluorescent anti-
body (red stain) and (D–F) detection of collagen adsorption using Picrosirius (red stain). A plain microscopic slide was
used as negative control. Microscopic slides coated with either collagen or fibronectin were used as positive controls and
were compared to PC-coated slides. Color images available online at www.liebertpub.com/tea
FIG. 3. Cell adhesion and viability of pulmonary valve endothelial cells (PVECs) and pulmonary valve interstitial cells
(PVICs) grown on PC. The upper left hand panel shows morphology of PVECs grown on slides with (A) gelatin, (B) PCwithout
plasma oxidation, (C) PC with plasma oxidation, (D) PC with plasma oxidation and coated with fibronectin, and (E) PC with
plasma oxidation coated with collagen. (F) Shows the number of adherent cells on slides treated with 10–1000mg/mL of either
collagen or fibronectin. Coating PC membranes with collagen significantly enhanced PVEC number when compared to cells
grown on slides coatedwith fibronectin (*p< 0.001,N= 4). The upper right hand panel shows themorphology of PVICs on slides
with (G) no coating, (H) PCwithout plasma oxidation, (I) PCwith plasma oxidation and coatedwith fibronectin, and (J)PCwith
plasma oxidation coated with collagen. (K) Shows the number of adherent cells on slides treated with 10–1000mg/mL of either
collagen or fibronectin. Coating PC with either collagen enhances PVIC number compared to control and slides coated with
fibronectin (#p< 0.05 [control compared to collagen], **p< 0.001 [collagen compared to fibronectin], respectively, N= 4).
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The adhesion of PVECs to plasma oxidized PC was tested
with different types of coatings and their morphology was
compared to gelatin-coated PC slides and plain gelatin-
coated glass slides. PVECs grown on collagen and fibro-
nectin showed comparable morphology to cells on glass and
plasma oxidized PC-only slides (Fig. 3C–E). The PVEC
number remained stable on collagen- and fibronectin-coated
slides at all concentrations studied compared to uncoated
slides; however, the cell number was significantly higher on
slides coated with 1000mg/mL of collagen compared to the
same slides coated with the same concentration of fibro-
nectin ( p < 0.01, n= 4) (Fig. 3F).
In contrast, PVICs are able to attach to plain uncoated
glass slides. The adhesion and morphology of PVICs
grown on plasma oxidized PC showed similar patterns to
those grown on uncoated glass slides, and plasma-treated
PC slides coated with collagen and fibronectin, with a
typical spindly morphology (Fig. 3G–J). The PVIC number
was enhanced when plasma oxidized PC slides were coated
with 10, 100, and 1000 mg/mL of collagen compared to
uncoated slides (n = 4, p < 0.005 and p < 0.001, respective-
ly), but not those coated with the same concentrations of
fibronectin. The cell number was significantly greater at all
coating concentrations on slides coated with collagen
compared to those coated with fibronectin ( p < 0.05, n = 4)
(Fig. 3K).
The incidence of apoptotic cells confirmed the MTS assay
findings, where programmed cell death percentage of PVECs
was less than 3.4% for all cells grown on all coatings (N= 2)
(Fig. 4A–G). In PVICs, cells grown on uncoated PC showed
slightly higher levels of apoptosis, where 13.9%– 2.5% of
cells were apoptotic ( p= 0.01), while coating PC with col-
lagen and fibronectin resulted in a lower incidence of apo-
ptosis of 6.82%– 0.56% ( p= 0.002) and 6.58%– 0.39%
( p= 0.002), respectively (N= 2) (Fig. 4H–N).
Mechanical properties of PC
Comparison to aortic valve biomechanics. Uniaxial test-
ing of different thicknesses of PC revealed that there is no
significant change in Young’s modulus for membranes of
thickness less than 11mm (n=4, p=0.77). However, a signif-
icant drop in the Young’s modulus was observed for the 30-
mm-thick membranes (n= 4, p<0.0001) in comparison with
each of the three other thicknesses of PC studied. In contrast,
yield strength and UTS did not show any significant difference
in PC films of different thicknesses (n=4, p=0.19 and
p=0.13, respectively) (Fig. 5).
PC mechanical properties in comparison to aortic valve.
Mechanical testing of the aortic valve revealed a significant
difference in the Young’s modulus between the circumfer-
ential (2.8 – 2.09) and the radial direction (0.6 – 0.19) (data
not shown). These findings agree with what was previously
reported by Li et al., where they showed that Young’s
modulus on the circumferential direction is six times higher
than that in the radial direction, due to the circumferential
orientation of the collagen fibers.20
To compare the aortic valve stiffness with that of PC, we
pooled the data of PC with thicknesses between 2 and 11 mm
FIG. 4. Effect of different coatings on the incidence of apoptosis. TUNEL and DAPI staining of PVECs (A–G) and PIVCs
(H–N) on different coatings. The negative control is where TdT enzyme was omitted, and the positive control is represented
with cells treated with H2O2. PVECs and PVICs were grown in standard culture conditions on slides coated with gelatin alone
(or plan microscopic slides for PVICs) and slides coated with PC and gelatin (or PC without coating for PVICs), collagen or
fibronectin. Cells cultured on PC with different coatings showed very low levels of apoptosis, with no significant difference
when compared to cells grown on microscopic slides. *p< 0.05. Color images available online at www.liebertpub.com/tea
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(since Young’s modulus was consistent in these films) and
compared the Young’s modulus of the aortic valve at the
radial and circumferential direction. The results suggest a
strong significance in the Young’s modulus between all PC
thicknesses with the aortic valve in both directions
( p < 0.0001) (Table 1).
Exposure of PC films to pulsatile pressure
PC films seeded with PVICs were exposed to pulsatile
pressure with a pressure profile of 0–50mmHg. After 3
days, cells on uncoated PC films and fibronectin-coated PC
were sparsely distributed, loosely attached, and they did not
express a fibroblast-like morphology (Fig. 6A, B). In con-
trast, cells on PC with collagen were more uniformly dis-
tributed, with good attachment and a spindle-like elongated
morphology (Fig. 6C).
Exposure of PC films to aortic flow pattern
PC films seeded with PVECs were exposed to the aortic
flow pattern. After 3 days of exposure, PVECs were still
attached to PC films, regardless of the coating. Due to the
PC films being very thin, once they have been peeled off it is
difficult to mount them completely flat on a coverslip. This
created different focal planes and the appearance of a sha-
ded area, although the staining was uniform (Fig. 6D, E).
Discussion
Biocompatibility and mechanical strength are important
factors in evaluating the suitability of synthetic materials for
future use in tissue engineering.21 In the current work, we
showed that ECM proteins are able to absorb onto plasma-
activated PC and allow PC to be biocompatible with en-
dothelial and interstitial cells. We also showed that different
thicknesses of PC exhibit a higher tensile strength and dis-
tensibility than aortic valve tissue.
Interactions of scaffolds used in tissue engineering with
the biological system are determined by their surface
chemistry. It is desirable to modify these surfaces in such a
manner that enhances interactions with cells.22 Cell adhe-
sion in vivo occurs through the binding of integrins on the
cell surface with specific regions of different ECM proteins.
Therefore, precoating the scaffold with ECM components
provides a favorable environment for cellular adhesion
which, in turn, facilitates their migration into the scaffold
and subsequent proliferation. The ability of the scaffold
material to adsorb ECM proteins is important in providing
such an environment.13 In addition, surface wettability is an
FIG. 5. Mechanical prop-
erties of different thicknesses
of PC. PC was tested for
Young’s modulus (A), yield
strength (B), and ultimate
tensile strength (UTS) (C).
Young’s modulus was the
same for thicknesses less
than 11 mm, but tended to
decrease in 30 mm thickness
( p < 0.0001, N = 4). UTS
and yield strength are not
affected by thickness.
(D) Table summarizes PC
mechanical properties of
different thicknesses.
Table 1. Stiffness of PC in Comparison to the Aortic Valve
PC Aortic valve
Sample PC (<11 lm) PC (30lm) Radial direction Circumferential direction
Young’s modulus (Mpa) 1008.6– 114.1 509.7– 16.8 0.64 – 0.2 2.82 – 2.09
PC, parylene C.
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important factor in enhancing cell adhesion and protein
adsorption.23 In this study, we applied two surface modifi-
cations to PC: first, we plasma oxidized PC to induce its
hydrophilicity, and then we coated the material with a range
of concentrations of ECM proteins to provide a favorable
environment for cellular adhesion and growth. Collagen and
fibronectin were chosen since type 1 collagen is the most
abundant type of collagen in the normal valve and fibro-
nectin is an important glycoprotein for interstitial cell re-
pair.24 In our experience, it was difficult to get the PC films
to lie completely flat, which made en face imaging and
quantification of the staining for collagen or fibronectin
problematic. Our findings suggest that ECM proteins are
able to bind to plasma-treated PC and that binding to col-
lagen promotes VIC proliferation and that VECs are more
proliferative when in contact with collagen compared to the
same concentrations of fibronectin.
Many studies had investigated the biocompatibility of PC
with the growth of different cell types, such as fibroblasts
(NIH 3T3), hepatocytes,12 human umbilical vain endothelial
cells,13 and retinal pigment epithelial cells.14 In addition, a
study by Schleicher et al. showed that PC exhibits low
thrombogenicity and excellent hemocompatibility after oli-
gonucleotide coating.13 In the current study, we showed that
cellular morphology, phenotype, and viability of PVECs and
PVICs grown on plasma-treated PC showed similar patterns
to cells grown in normal in vitro conditions.
Since interstitial and endothelial cells are the two resident
cell types in the normal valve, studying their growth be-
havior and functionality is a crucial step in evaluating PC
suitability as a valve scaffold. Although some studies re-
ported the use of fully differentiated interstitial and endo-
thelial cells in valve implants, this approach is associated
with surgical intervention to harvest donor vascular tissue
from which cells can be isolated and expanded in culture.25
An effective alternative is to use stem cells that have the
ability to differentiate and function as valve interstitial and
endothelial cells. A recent study showed that adipose-de-
rived stem cells exhibit the ability to produce and remodel
ECM proteins.17 Schmidt et al. showed the ability of en-
dothelial progenitor cells derived from peripheral blood to
endothelialize TEHV in vivo.26 The next step should be to
test the compatibility of PC with the growth and function-
ality of stem cells and to study their ability to differentiate
and secrete their own ECM over a longer time frame than
used in the current study.
The biocompatibility of the scaffold should be combined
with mechanical strength equivalent to that of the normal
valve. We tested the mechanical properties of PC at four
different thicknesses (2, 5, 11, and 30 mm) and found that all
four thicknesses possess a high elastic modulus (509.7–
1008.5MPa), which is more than 180-fold higher compared
with the normal valve. Our findings also suggest that PC of
thicknesses up to 11 mm exhibit the same range of stiffness
with no significant difference, while the highest thickness
showed a significant decrease in the elastic modulus. In
theory, the elastic modulus should not be affected by the
thickness, since it is normalized to the cross-sectional area
of the sample. Our findings could be related to an increase
of the material’s surface roughness that is associated with
FIG. 6. Effect of exposure to flow and pressure in PVECs and PVICs, respectively. PVICs exposed to 0–50mmHg
cyclical pressure at a frequency of 1.0Hz seeded on PC films uncoated (A), coated with fibronectin (B) and collagen (C),
and stained for Vimentin and nuclei counterstained with DAPI. PVECs exposed to aortic flow pattern for 3 days on PC films
uncoated (D), coated with collagen (E), and stained with TRITC-conjugated phalloidin. Scale bars = 50 mm. Color images
available online at www.liebertpub.com/tea
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increased thickness. This has not been proved for PC and
we could not find any studies investigating the effect of
thickness on the elastic modulus except in the nanoscale.
Another possibility is that sample processing before me-
chanical testing affected the obtained results and that this
trend is associated with technical errors rather than being
an actual decrease. Handling very thin films presented a
number of technical difficulties in loading the thin films
onto the testing rig. These included unintentional stretch-
ing of the sample before loading, positioning in the clamps
of the test rig, and the ability of the clamp to hold the
membranes tightly. Some of these issues were solved by
first fixing the sample to the clamp using tape, while they
were closed tightly. However, it was clear from the data
obtained that the mechanical strength of PC in all thick-
nesses studied is highly resistant to fracture and plastic
deformation, as indicated by their high yield strength and
UTS.
Although our initial data showed that PVICs attached well
to both fibronectin- and collagen-coated films, those exper-
iments were performed into a static environment without any
dynamic conditioning. To test the PC-seeded films in a more
physiological environment, we exposed them to pulsatile
pressure and to the aortic flow pattern. While the cells re-
mained attached to the PC under conditions of pressure and
flow, regardless of which ECM coating was used, the data
obtainable on the phenotype of the cells were limited due to
technical issues. Since collagen contains many different cell-
binding sites compared to fibronectin, it is possible that with
the exposure to pulsatile pressure or flow, the phenotype of
cells may differ when compared to either PC only or fibro-
nectin. A second consideration is the stiffness of the under-
lying substrate. There will be a significant influence of the
stiffness of the glass slides used in the first part of this study
compared to when the PC is mounted as a free unsupported
material in the pulsatile bioreactor. Additional studies are
required to ascertain the exact influence of the stiffness of PC
on cell function and phenotype under physiological condi-
tions of flow (using flow patterns experienced by either
surface of the valve) and pressure.
This study has utilized pulmonary valve VICs and VECs.
Phenotypically, these cells are similar to those isolated from
the aortic valve27,28; however, some differences have been
reported in the remodeling response of cells from each
valve.29 The data presented in this study with pulmonary
valve cells serve mainly as a proof on concept that valve
cells can adhere and proliferate on plasma-activated PC
coated with ECM proteins. Further studies should focus on
the remodeling potential of the cells as well as on the use of
human valve cells, ideally from the aortic valve.
Our preliminary findings suggest that PC holds a promise
for successful use as a scaffolding material for TEHV. Its
proven biocompatibility with the biological system, in
combination with its high mechanical properties, and the
ability to enhance the adhesion and phenotypic character-
istics of valve cells indicate that it is a good candidate for
future use. PC overcomes other synthetic polymers like
PGA and PLA with their relatively lower level of biocom-
patibility, as evidenced by their poor rate of cell growth.4 In
addition, these polymers are nonpliable, in contrast to the
flexible nature of PC that could be easily modified and
fabricated to cope with TEHV requirements.
There are a number of potential limitations to the use of PC,
which include a lack of porosity,14 a lack of anisotropy in its
mechanical properties, and the fact that the stiffness of the ma-
terial is an order of magnitude greater compared with the native
valve. These limitations would prevent cellular migration into
the structure of the scaffold and would provide a miss-match to
the normal mechanical properties of native valve tissue. How-
ever, there are various strategies that could be employed to
circumvent these limitations. In addition, the current studies of
the effect of PC on cells under physiological conditions were
only performed over a short time frame (3 days). Validation of
the apparatus used in these experiments containing cells and PC
over a much greater time frame is required before longer term
experiments can be reliably performed.
Porosity could be changed by introducing holes to the PC
films through standard lithographic techniques and oxygen
plasma etching,16 which has been demonstrated to be fea-
sible through cell patterning experiments.30 Porosity of the
scaffolding material is important for cell growth and mi-
gration, which allows ECM secretion and three-dimensional
(3D) regeneration of the tissue.21 Pores are also effective in
decreasing necrosis caused by clustering of cells, where cell
growth will be confined to the size of the pore.31
In the native valve, the collagen matrix is highly orga-
nized in a way that provides the necessary strength cir-
cumferentially and the flexibility in the radial direction.32
Previous studies showed that PC could be fabricated in the
form of nanowires by vapor deposition from a directional
vapor source, which exhibits anisotropic mechanical fea-
tures, in addition to porosity.33
With regard to the stiffness of PC films, this could be
adjusted by mixing PC with other polymeric materials such
as polycaprolactone (PCL), which is a biocompatible bio-
degradable polymer that could be manufactured in a unique
porous structure, therefore neutralizing the strength of PC.
In addition, it had been previously shown that there is an
inverse relationship between Young’s modulus and porosity,
thus creating pores in PC membranes, as mentioned above,
may also potentially decrease the stiffness to a desirable
level.34,35 The potential to make composite scaffolds with
other materials remains a possibility. This may include the
synthesis of sandwich scaffolds containing a layer of PC.
This study illustrates that if PC is incorporated into the body
of the scaffold, then it can be compatible with ECM proteins
and cells that may populate the scaffold.
As a first step, further studies are required to gain additional
information about the interaction of PC with cells that may be
used in TEHV. The biocompatibility of PC with stem cells of
different sources (bone marrow, adipose tissue, and others)
should be studied. In addition, evaluating the ability of the
cells to survive and function for prolonged periods is crucial
and will provide a better understanding of cell behavior and
growth pattern on PC. Furthermore, different strategies to
decorate the surface of PC with protein sequences that will
attract and bind specific cell types can be developed to max-
imize cell attachment in vitro or in vivo. Models for fabri-
cating PC scaffolds for TEHV could also include the
development of 3D PC scaffold through layer-by-layer as-
sembly of PC thin nanowires with cells seeding on each layer.
In conclusion, this study showed that PC is compatible
with valve cells and ECM adsorption. The in vivo behavior
of this scaffold needs to be evaluated.
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